User's guide to JAK inhibitors in inflammatory bowel disease
Author:
Publisher
Elsevier BV
Subject
Animal Science and Zoology,Ecology, Evolution, Behavior and Systematics
Reference74 articles.
1. JAK inhibitors safety in ulcerative colitis: practical implications;Agrawal;J. Crohns Colitis,2020
2. Novel and emerging therapies for inflammatory bowel disease;Al-Bawardy;Front. Pharmacol.,2021
3. Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: a retrospective case-control study;Berinstein;Clin. Gastroenterol. Hepatol.,2021
4. Maintenance therapy options for ulcerative colitis;Chaparro;Expet Opin. Pharmacother.,2016
5. Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib;Chimenti;Ther. Adv. Musculoskelet Dis.,2021
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases;Journal of Clinical Medicine;2024-08-09
2. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation;Molecules;2024-03-19
3. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14
4. Inflammatory Bowel Disease;Care of Adults with Chronic Childhood Conditions;2024
5. Cardiovascular implications of inflammatory bowel disease: An updated review;World Journal of Cardiology;2023-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3